Endogenous versus exogenous generic reference pricing for pharmaceuticals
Sign Up to like & getrecommendations! Published in 2017 at "International Journal of Health Economics and Management"
DOI: 10.1007/s10754-017-9216-x
Abstract: In this paper we carry out a vertical differentiation duopoly model applied to pharmaceutical markets to analyze how endogenous and exogenous generic reference pricing influence competition between generic and branded drugs producers. Unlike the literature,… read more here.
Keywords: reference pricing; reference; price; health ... See more keywords
Does the Implementation of Reference Pricing Result in Reduced Utilization? Evidence From Inpatient and Outpatient Procedures
Sign Up to like & getrecommendations! Published in 2020 at "Medical Care Research and Review"
DOI: 10.1177/1077558720971117
Abstract: Reference pricing (RP) is an insurance design that can be used to incentivize patients to use low-price settings. While RP is not intended to affect overall utilization, it could unintentionally reduce utilization. We examined whether… read more here.
Keywords: reference pricing; implementation; evidence; outpatient ... See more keywords
Using External Reference Pricing In Medicare Part D To Reduce Drug Price Differentials With Other Countries.
Sign Up to like & getrecommendations! Published in 2019 at "Health affairs"
DOI: 10.1377/hlthaff.2018.05207
Abstract: Many countries use external reference pricing to help determine drug prices. However, external reference pricing has received little attention in the US-perhaps because the US is often the first adopter of drugs. External reference pricing… read more here.
Keywords: reference pricing; reference; price; external reference ... See more keywords
Germany's Use Of Reference Pricing For Biologics: Lessons For The US.
Sign Up to like & getrecommendations! Published in 2022 at "Health affairs"
DOI: 10.1377/hlthaff.2022.00123
Abstract: A redesign of consumer cost sharing in the United States is important to accelerate the adoption of biosimilars and price reductions for biologics. This article analyzes therapeutic reference pricing for anti-inflammatory biosimilars in Germany and… read more here.
Keywords: reference; cost sharing; use reference; reference pricing ... See more keywords
Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.815029
Abstract: Background: External reference pricing (ERP) is used to set pharmaceutical prices to improve affordability, but its application may have negative consequences on patient access—thus, equity—across countries and on global innovation. With the United States contemplating… read more here.
Keywords: medicine; patient access; access; external reference ... See more keywords